Notably, these results identified RRM2 as a carcinogenic marker for ACC, LGG, KIRP, LIHC, KIRC, PAAD, and LUAD prognosis, regardless of the prognostic algorithm. Here, RRM2 is linked to adrenal cortex carcinoma.